Article metrics

Download PDFPDF

285 Phase I clinical trial evaluating the safety of ADP-A2M10 in patients with MAGE-A10+ head and neck, melanoma, or urothelial tumors

 

Online download statistics by month:

Online download statistics by month: November 2020 to June 2025

AbstractFullPdf
Nov 2020122017
Dec 20203608
Jan 20211906
Feb 202118012
Mar 20212606
Apr 20212909
May 2021704
Jun 2021008
Jul 2021009
Aug 2021006
Sep 2021004
Oct 202114020
Nov 202112014
Dec 20211202
Jan 20221000
Feb 20222002
Mar 20222604
Apr 20224404
May 20221401
Jun 20221403
Jul 20221202
Aug 20222202
Sep 20222202
Oct 20221601
Nov 20222401
Dec 20222602
Jan 202330010
Feb 20234404
Mar 20231201
Apr 2023803
May 20231402
Jun 20232207
Jul 20231804
Aug 20232805
Sep 20231203
Oct 20231804
Nov 20232402
Dec 20234203
Jan 20241800
Feb 20241801
Mar 20241801
Apr 20241400
May 20241201
Jun 20241403
Jul 20246003
Aug 20241803
Sep 20241805
Oct 20242806
Nov 20241803
Dec 20241403
Jan 20252607
Feb 2025209
Mar 2025003
Apr 2025009
May 2025004
Jun 2025004
Total10950262